258 related articles for article (PubMed ID: 26444494)
21. Acute myeloid leukemia: leukemia stem cells write a prognostic signature.
Gudgin EJ; Huntly BJ
Stem Cell Res Ther; 2011 Apr; 2(2):21. PubMed ID: 21539722
[TBL] [Abstract][Full Text] [Related]
22. Cell division patterns in acute myeloid leukemia stem-like cells determine clinical course: a model to predict patient survival.
Stiehl T; Baran N; Ho AD; Marciniak-Czochra A
Cancer Res; 2015 Mar; 75(6):940-9. PubMed ID: 25614516
[TBL] [Abstract][Full Text] [Related]
23. Phosphoinositide-dependent kinase 1 regulates leukemia stem cell maintenance in MLL-AF9-induced murine acute myeloid leukemia.
Hu T; Li C; Zhang Y; Wang L; Peng L; Cheng H; Wang W; Chu Y; Xu M; Cheng T; Yuan W
Biochem Biophys Res Commun; 2015 Apr; 459(4):692-8. PubMed ID: 25769952
[TBL] [Abstract][Full Text] [Related]
24. Lymphoid progenitors as candidate cancer stem cells in AML: new perspectives.
Deshpande AJ; Buske C
Cell Cycle; 2007 Mar; 6(5):543-5. PubMed ID: 17329976
[TBL] [Abstract][Full Text] [Related]
25. CD200 expression marks leukemia stem cells in human AML.
Ho JM; Dobson SM; Voisin V; McLeod J; Kennedy JA; Mitchell A; Jin L; Eppert K; Bader G; Minden MD; Dick JE; Wang JCY
Blood Adv; 2020 Nov; 4(21):5402-5413. PubMed ID: 33147339
[TBL] [Abstract][Full Text] [Related]
26. [Progress in the studies of acute myelogenous leukemia stem cell].
Cui JW; Zhang XM; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):549-52. PubMed ID: 14575558
[TBL] [Abstract][Full Text] [Related]
27. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication.
de Leeuw DC; Denkers F; Olthof MC; Rutten AP; Pouwels W; Schuurhuis GJ; Ossenkoppele GJ; Smit L
Cancer Res; 2014 Apr; 74(7):2094-105. PubMed ID: 24477595
[TBL] [Abstract][Full Text] [Related]
28. GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo.
Pabst C; Bergeron A; Lavallée VP; Yeh J; Gendron P; Norddahl GL; Krosl J; Boivin I; Deneault E; Simard J; Imren S; Boucher G; Eppert K; Herold T; Bohlander SK; Humphries K; Lemieux S; Hébert J; Sauvageau G; Barabé F
Blood; 2016 Apr; 127(16):2018-27. PubMed ID: 26834243
[TBL] [Abstract][Full Text] [Related]
29. Leukaemia cell of origin identified by chromatin landscape of bulk tumour cells.
George J; Uyar A; Young K; Kuffler L; Waldron-Francis K; Marquez E; Ucar D; Trowbridge JJ
Nat Commun; 2016 Jul; 7():12166. PubMed ID: 27397025
[TBL] [Abstract][Full Text] [Related]
30. Leukemia stem cells.
Buss EC; Ho AD
Int J Cancer; 2011 Nov; 129(10):2328-36. PubMed ID: 21796620
[TBL] [Abstract][Full Text] [Related]
31. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.
de Jonge HJ; Woolthuis CM; Vos AZ; Mulder A; van den Berg E; Kluin PM; van der Weide K; de Bont ES; Huls G; Vellenga E; Schuringa JJ
Leukemia; 2011 Dec; 25(12):1825-33. PubMed ID: 21760593
[TBL] [Abstract][Full Text] [Related]
33. Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia.
Yang XH; Li M; Wang B; Zhu W; Desgardin A; Onel K; de Jong J; Chen J; Chen L; Cunningham JM
BMC Bioinformatics; 2015 Mar; 16():97. PubMed ID: 25887548
[TBL] [Abstract][Full Text] [Related]
34. [Expression of HoxA10 in acute leukemia and its significance].
Huang Y; Li WJ; Wei CX; Zhou Z; Nie B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):959-63. PubMed ID: 16403259
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
Jost E; Schmid J; Wilop S; Schubert C; Suzuki H; Herman JG; Osieka R; Galm O
Br J Haematol; 2008 Sep; 142(5):745-53. PubMed ID: 18537968
[TBL] [Abstract][Full Text] [Related]
36. Acute myeloid leukemia stem cells.
Dick JE
Ann N Y Acad Sci; 2005 Jun; 1044():1-5. PubMed ID: 15958691
[TBL] [Abstract][Full Text] [Related]
37. The expression and regulation of HOX genes and membrane proteins among different cytogenetic groups of acute myeloid leukemia.
Wang H; Lin SY; Hu FF; Guo AY; Hu H
Mol Genet Genomic Med; 2020 Sep; 8(9):e1365. PubMed ID: 32614525
[TBL] [Abstract][Full Text] [Related]
38. TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia.
Kikushige Y; Akashi K
Ann N Y Acad Sci; 2012 Aug; 1266():118-23. PubMed ID: 22901263
[TBL] [Abstract][Full Text] [Related]
39. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
40. Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions.
Benetatos L; Dasoula A; Hatzimichael E; Syed N; Voukelatou M; Dranitsaris G; Bourantas KL; Crook T
Ann Hematol; 2011 Sep; 90(9):1037-45. PubMed ID: 21340720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]